<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7115022/results/search/test_trace/results.xml">
  <result pre="critical importance of prevention. Viral transmission may be interrupted by" exact="contact" post="isolation with droplet precautions for infected patients and by"/>
  <result pre="importance of prevention. Viral transmission may be interrupted by contact" exact="isolation" post="with droplet precautions for infected patients and by having"/>
  <result pre="new diagnostic methods and introduction of antiviral drugs, this increased" exact="infection" post="rate has rekindled interest in the effects of common"/>
  <result pre="by disparities in the type of patients enrolled, reasons for" exact="screening" post="patients for respiratory viruses and, most importantly, diagnostic methods"/>
  <result pre="respiratory viruses in immunocompromised patients are closely related to the" exact="prevalence" post="of respiratory viruses in the community, which serves as"/>
  <result pre="feature of adenoviruses is the ability to cause chronic latent" exact="infection" post="by persisting in lymphoepithelial tissues, most notably in the"/>
  <result pre="on their epidemiology are still limited. Recent studies using rt-PCR" exact="detection" post="of respiratory viruses in patients with HM revealed a"/>
  <result pre="[29, 32–34]. About one-third of patients develop lower respiratory tract" exact="infection" post="(LRTI). Although less common than in previous reports, influenza-related"/>
  <result pre="15–30% mortality rate. As in immunocompetent hosts, upper respiratory tract" exact="infection" post="(URTI) is almost always present and often precedes LRTI"/>
  <result pre="52]. URTI can be considered a useful argument supporting the" exact="diagnosis" post="of respiratory viral infection in patients with HM investigated"/>
  <result pre="considered a useful argument supporting the diagnosis of respiratory viral" exact="infection" post="in patients with HM investigated for pneumonia [53]. However,"/>
  <result pre="pneumonia in patients with HM are often ascribed to viral" exact="infection" post="[53]. However, bacterial co-infections were present in as many"/>
  <result pre="case reports [8, 56]. However, no extra-respiratory manifestations of RSV" exact="infection" post="have been described in immunocompromised patients. PIV infections have"/>
  <result pre="in a recent study using rt-PCR for routine respiratory virus" exact="detection" post="in HSCT recipients, PIV was found in respiratory samples"/>
  <result pre="therapy in the study by Nichols et al., since this" exact="treatment" post="is often given to treat graft-versus-host disease (GVHD) after"/>
  <result pre="In allogeneic transplant recipients, the most frequent manifestations of adenoviral" exact="infection" post="are gastrointestinal disease and haemorrhagic cystitis [95, 96]. Although"/>
  <result pre="haemorrhagic diarrhoea [95, 98]. The most severe manifestations of adenoviral" exact="infection" post="are hepatitis, encephalitis, and pneumonia [86, 89, 90]. Adenovirus-related"/>
  <result pre="pneumonia occurred in 15 of the 85 patients with adenovirus" exact="infection" post="in the study by La Rosa et al. [89]."/>
  <result pre="diagnosis, without practical consequences for the patient. Recently, however, the" exact="diagnosis" post="of viral respiratory infection has become increasingly relevant for"/>
  <result pre="for the patient. Recently, however, the diagnosis of viral respiratory" exact="infection" post="has become increasingly relevant for medical care [100, 101]."/>
  <result pre="for some respiratory viruses, including influenza and adenovirus. Several diagnostic" exact="tests" post="have been introduced for the detection of respiratory viruses."/>
  <result pre="and adenovirus. Several diagnostic tests have been introduced for the" exact="detection" post="of respiratory viruses. The main characteristics of the most"/>
  <result pre="staining ++ ++ &amp;lt;3 h &amp;lt;8 15–25 Euros Rapid antigen" exact="testing" post="(immunochromatography) + +/++ &amp;lt;1 h Only available for influenza"/>
  <result pre="panel High-quality clinical specimens are needed to ensure the accurate" exact="detection" post="of respiratory viruses. Indeed, respiratory virus detection requires a"/>
  <result pre="ensure the accurate detection of respiratory viruses. Indeed, respiratory virus" exact="detection" post="requires a large number of epithelial cells, since viruses"/>
  <result pre="epithelial cells [105, 106], and were recently recommended for the" exact="diagnosis" post="of the new pandemic H1N1 influenza strain. The number"/>
  <result pre="than with nasopharyngeal aspirates, but seems sufficient for respiratory virus" exact="detection" post="by immunofluorescence [105, 106]. Flocked swab collection is sensitive,"/>
  <result pre="be followed by LRTI, particularly during influenza infections. Thus, virus" exact="detection" post="in lungs via bronchoalveolar lavage may be useful to"/>
  <result pre="role for the virus. Over the past 2 decades, virus" exact="isolation" post="and antigen detection have been the mainstay of clinical"/>
  <result pre="virus. Over the past 2 decades, virus isolation and antigen" exact="detection" post="have been the mainstay of clinical laboratory testing for"/>
  <result pre="and antigen detection have been the mainstay of clinical laboratory" exact="testing" post="for respiratory virus infections. Virus isolation required several cell"/>
  <result pre="mainstay of clinical laboratory testing for respiratory virus infections. Virus" exact="isolation" post="required several cell lines and was mainly performed on"/>
  <result pre="lines and was mainly performed on shell vial cultures. The" exact="diagnosis" post="was based on the presence of the cytopathic effect,"/>
  <result pre="to diagnosis, specific monoclonal antibodies were introduced to enable the" exact="detection" post="of specific viral antigens within 1–2 days. Direct or"/>
  <result pre="agents, cannot be detected using monoclonal antibodies. Nucleic acid amplification" exact="tests" post="have been proven to be rapid, very sensitive, and"/>
  <result pre="respiratory viruses, the need to carry out as many PCR" exact="tests" post="as targets has limited the use of this method."/>
  <result pre="that use agarose gel electrophoresis or capillary electrophoresis as the" exact="detection" post="system or multiplex PCR assays combined with an enzyme-linked"/>
  <result pre="amplified DNA products are captured by the probes [114]. Multiplex" exact="detection" post="based on Luminex technology. The PCR products are coupled"/>
  <result pre="electrophoresis methods [117, 118]. Mass spectrometry assays for respiratory virus" exact="detection" post="are based on the analysis of base compositions in"/>
  <result pre="This step increases the time to results compared to antigen" exact="detection" post="by fluorescent staining. Molecular assays should be performed as"/>
  <result pre="day. Few data are available on the exhaustive and sensitive" exact="detection" post="of respiratory viruses in HM patients. Recent data show"/>
  <result pre="Recent data show that using molecular assays increases the virus" exact="detection" post="rate twofold compared to cultures and fourfold compared to"/>
  <result pre="data emphasise the need for prospective studies of the molecular" exact="detection" post="of respiratory viruses to elucidate factors associated with symptomatic"/>
  <result pre="to elucidate factors associated with symptomatic or asymptomatic respiratory viral" exact="infection" post="and to help in the interpretation of positive assays"/>
  <result pre="RSV. Two classes of antiviral drugs are available for the" exact="treatment" post="of influenza: M2 ion channel inhibitors and neuraminidase inhibitors."/>
  <result pre="in these cohorts had bacterial and fungal co-infections, whose specific" exact="treatment" post="probably contributed to decreasing mortality. Furthermore, the decision to"/>
  <result pre="indications Ribavirin is the only available antiviral drug for Paramyxoviridae" exact="infection" post="(Table 21.3). The efficacy of aerosolized ribavirin was variable"/>
  <result pre="some authors to evaluate pre-emptive ribavirin therapy, characterised by ribavirin" exact="treatment" post="of RSV URTI to prevent progression to pneumonia [133,"/>
  <result pre="controlled trial evaluating pre-emptive ribavirin therapy in patients with RSV" exact="infection" post="[133]. Unfortunately, the trial did not enrol a sufficient"/>
  <result pre="patients with HM. No controlled randomised study has evaluated the" exact="treatment" post="of adenoviral disease in patients with HM. Ribavirin and"/>
  <result pre="with HM. Ribavirin and cidofovir have been suggested for the" exact="treatment" post="of adenoviral infections, but only uncontrolled cohort studies are"/>
  <result pre="decreasing the level of immunosuppression seems to be a rational" exact="treatment" post="approach [155]. T-cell therapy has also been reported in"/>
  <result pre="been reported in some small series [155, 156]. Early cidofovir" exact="treatment" post="seems associated with a better outcome [151]. Weekly PCR"/>
  <result pre="treatment seems associated with a better outcome [151]. Weekly PCR" exact="screening" post="for adenovirus viraemia has been suggested to guide pre-emptive"/>
  <result pre="patients and from infected health-care workers. Infection control measures include" exact="screening" post="symptomatic patients for common respiratory viruses, early isolation of"/>
  <result pre="measures include screening symptomatic patients for common respiratory viruses, early" exact="isolation" post="of infected patients, screening health-care workers and visitors for"/>
  <result pre="patients for common respiratory viruses, early isolation of infected patients," exact="screening" post="health-care workers and visitors for respiratory symptoms, and avoiding"/>
  <result pre="screening health-care workers and visitors for respiratory symptoms, and avoiding" exact="contact" post="of symptomatic individuals with patients. Most haematologic wards do"/>
  <result pre="of standard hygiene measures, especially hand hygiene before and after" exact="contact" post="with patients, is also strongly recommended. Awareness of the"/>
  <result pre="the common respiratory viruses are transmitted by droplets or direct" exact="contact" post="of infected secretions with the nasal mucosa or conjunctiva."/>
  <result pre="survive several hours on these surfaces [6, 7, 58]. Consequently," exact="contact" post="isolation of infected patients combined with droplet precautions is"/>
  <result pre="several hours on these surfaces [6, 7, 58]. Consequently, contact" exact="isolation" post="of infected patients combined with droplet precautions is mandatory"/>
  <result pre="that asymptomatic viral shedding, when present, limits the effectiveness of" exact="infection" post="control measures [30, 65]. The optimal duration of isolation"/>
  <result pre="of infection control measures [30, 65]. The optimal duration of" exact="isolation" post="is unknown. Whether isolation should be prolonged in asymptomatic"/>
  <result pre="[30, 65]. The optimal duration of isolation is unknown. Whether" exact="isolation" post="should be prolonged in asymptomatic patients with persistent low-titre"/>
  <result pre="86] and, therefore, may not be effectively prevented by standard" exact="infection" post="control measures. Table 21.4 Infection control measures for common"/>
  <result pre="Table 21.4 Infection control measures for common respiratory viruses Specific" exact="infection" post="control measures Screening patients for respiratory virus infections Contact"/>
  <result pre="infection control measures Screening patients for respiratory virus infections Contact" exact="isolation" post="with droplet precautions for infected patients Screening visitors and"/>
  <result pre="children Enhanced standard precautions Reinforced hand hygiene before and after" exact="contact" post="with patients Annual influenza immunisation Patients with HM Family"/>
  <result pre="infections. Intravenous immunoglobulins and palivizumab have been suggested for RSV" exact="infection" post="prevention, but have not been evaluated in patients with"/>
  <result pre="to limit the risk of progression to pneumonia. The pre-emptive" exact="treatment" post="of viral URTI has been discussed above. Given the"/>
  <result pre="virus and parainfluenza virusN Engl J Med2001344251917192811419430 8.FalseyARWalshEERespiratory syncytial virus" exact="infection" post="in adultsClin Microbiol Rev200013337138410885982 9.HallCBMccarthyCAMandellGRespiratory Syncytial VirusPrinciples and practice"/>
  <result pre="diseases20056Philadelphia, PAChurchill Livingstone1624 24.MatsuzakiYet al.Clinical features of influenza C virus" exact="infection" post="in childrenJ Infect Dis200619391229123516586359 25.TurnerDet al.Systematic review and economic"/>
  <result pre="al.Systematic review and economic decision modelling for the prevention and" exact="treatment" post="of influenza A and BHealth Technol Assess2003735iiiiv14609480 26.DushoffJet al.Mortality"/>
  <result pre="virus in humansN Engl J Med2009360252605261519423869 28.FalseyARet al.Respiratory syncytial virus" exact="infection" post="in elderly and high-risk adultsN Engl J Med2005352171749175915858184 29.LjungmanPet"/>
  <result pre="for Blood and Marrow TransplantationBone Marrow Transplant200128547948411593321 30.PeckAJet al.Respiratory virus" exact="infection" post="among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza"/>
  <result pre="Blood Marrow Transplant2005111078179616182179 37.Kolavic-GraySAet al.Large epidemic of adenovirus type 4" exact="infection" post="among military trainees: epidemiological, clinical, and laboratory studiesClin Infect"/>
  <result pre="transplant unitJ Clin Microbiol1998368228922939666007 45.EltingLSet al.Epidemiology of influenza A virus" exact="infection" post="in patients with acute or chronic leukemiaSupport Care Cancer1995331982027655781"/>
  <result pre="bone marrow transplant centerJ Infect Dis199216569879931583345 47.KhannaNet al.Respiratory syncytial virus" exact="infection" post="in patients with hematological diseases: single-center study and review"/>
  <result pre="tract diseaseBone Marrow Transplant200331430931012621469 60.EnglundJAet al.Brief communication: fatal human metapneumovirus" exact="infection" post="in stem-cell transplant recipientsAnn Intern Med2006144534434916520475 61.PelletierGet al.Respiratory tract"/>
  <result pre="immunocompromised childEmerg Infect Dis20028997697812194777 62.KambojMet al.Clinical characterization of human metapneumovirus" exact="infection" post="among patients with cancerJ Infect200857646447119027169 63.OliveiraRet al.Frequency of human"/>
  <result pre="among patients with cancerJ Infect200857646447119027169 63.OliveiraRet al.Frequency of human metapneumovirus" exact="infection" post="in hematopoietic SCT recipients during 3 consecutive yearsBone Marrow"/>
  <result pre="infectionsJ Infect Dis200519261061106516107960 65.DebiaggiMet al.Long-term study on symptomless human metapneumovirus" exact="infection" post="in hematopoietic stem cell transplant recipientsNew Microbiol200730325525817802904 66.KaidaAet al.Seasonal"/>
  <result pre="74.GutmanJAet al.Rhinovirus as a cause of fatal lower respiratory tract" exact="infection" post="in adult stem cell transplantation patients: a report of"/>
  <result pre="90.BaldwinAet al.Outcome and clinical course of 100 patients with adenovirus" exact="infection" post="following bone marrow transplantationBone Marrow Transplant200026121333133811223974 91.LionTet al.Molecular monitoring"/>
  <result pre="in peripheral blood after allogeneic bone marrow transplantation permits early" exact="diagnosis" post="of disseminated diseaseBlood200310231114112012702513 92.EchavarriaMet al.Prediction of severe disseminated adenovirus"/>
  <result pre="diagnosis of disseminated diseaseBlood200310231114112012702513 92.EchavarriaMet al.Prediction of severe disseminated adenovirus" exact="infection" post="by serum PCRLancet2001358927938438511502321 93.ErardVet al.Quantitative real-time polymerase chain reaction"/>
  <result pre="by serum PCRLancet2001358927938438511502321 93.ErardVet al.Quantitative real-time polymerase chain reaction for" exact="detection" post="of adenovirus after T cell-replete hematopoietic cell transplantation: viral"/>
  <result pre="adenovirus DNA in serum correlate with fatal outcome of adenovirus" exact="infection" post="in children after allogeneic stem-cell transplantationClin Infect Dis200235552653212173125 95.BrunoBet"/>
  <result pre="in children after allogeneic stem-cell transplantationClin Infect Dis200235552653212173125 95.BrunoBet al.Adenovirus" exact="infection" post="in hematopoietic stem cell transplantation: effect of ganciclovir and"/>
  <result pre="ganciclovir and impact on survivalBiol Blood Marrow Transplant20039534135212766884 96.HaleGAet al.Adenovirus" exact="infection" post="after pediatric bone marrow transplantationBone Marrow Transplant199923327728210084260 97.BrunoBet al.Adenovirus"/>
  <result pre="chronic underlying conditionsJAMA2000283449950510659876 100.BarenfangerJet al.Clinical and financial benefits of rapid" exact="detection" post="of respiratory viruses: an outcomes studyJ Clin Microbiol20003882824282810921934 101.WooPCet"/>
  <result pre="viruses: an outcomes studyJ Clin Microbiol20003882824282810921934 101.WooPCet al.Cost-effectiveness of rapid" exact="diagnosis" post="of viral respiratory tract infections in pediatric patientsJ Clin"/>
  <result pre="Infect Dis J199312119229258265282 103.HeikkinenTet al.Nasal swab versus nasopharyngeal aspirate for" exact="isolation" post="of respiratory virusesJ Clin Microbiol200240114337433912409425 104.StensballeLGet al.Comparison of nasopharyngeal"/>
  <result pre="104.StensballeLGet al.Comparison of nasopharyngeal aspirate and nasal swab specimens for" exact="detection" post="of respiratory syncytial virus in different settings in a"/>
  <result pre="105.Abu-DiabAet al.Comparison between pernasal flocked swabs and nasopharyngeal aspirates for" exact="detection" post="of common respiratory viruses in samples from childrenJ Clin"/>
  <result pre="from uninfected volunteers and symptomatic patientsJ Clin Microbiol20064462265226716757636 107.GunsonRNCollinsTCCarmanWFReal-time RT-PCR" exact="detection" post="of 12 respiratory viral infections in four triplex reactionsJ"/>
  <result pre="of the one-step multiplex real-time reverse transcription-PCR ProFlu-1 assay for" exact="detection" post="of influenza A and influenza B viruses and respiratory"/>
  <result pre="110.TempletonKEet al.Rapid and sensitive method using multiplex real-time PCR for" exact="diagnosis" post="of infections by influenza a and influenza B viruses,"/>
  <result pre="single-tube multiplex reverse transcription-PCR: feasibility studyJ Clin Microbiol1999371179854054 112.LegoffJet al.High" exact="prevalence" post="of respiratory viral infections in patients hospitalized in an"/>
  <result pre="assay with conventional viral culture and immunofluorescence techniques for the" exact="detection" post="of seven viral respiratory pathogensJ Clin Microbiol20013982779278311473991 114.CannonGAet al.A"/>
  <result pre="Clin Microbiol20013982779278311473991 114.CannonGAet al.A low density oligonucleotide microarray for the" exact="detection" post="of viral and atypical bacterial respiratory pathogensJ Virol Methods20101631172419638287"/>
  <result pre="viral and atypical bacterial respiratory pathogensJ Virol Methods20101631172419638287 115.LiHet al.Simultaneous" exact="detection" post="and high-throughput identification of a panel of RNA viruses"/>
  <result pre="Luminex xTAG respiratory viral panel with in-house nucleic acid amplification" exact="tests" post="for diagnosis of respiratory virus infectionsJ Clin Microbiol20084693056306218632902 117.DominguezSRet"/>
  <result pre="respiratory viral panel with in-house nucleic acid amplification tests for" exact="diagnosis" post="of respiratory virus infectionsJ Clin Microbiol20084693056306218632902 117.DominguezSRet al.Multiplex MassTag-PCR"/>
  <result pre="respiratory pathogens in pediatric nasopharyngeal washes negative by conventional diagnostic" exact="testing" post="shows a high prevalence of viruses belonging to a"/>
  <result pre="nasopharyngeal washes negative by conventional diagnostic testing shows a high" exact="prevalence" post="of viruses belonging to a newly recognized rhinovirus cladeJ"/>
  <result pre="by mass spectrometryPLoS ONE200725e48917534439 120.KuypersJet al.Comparison of conventional and molecular" exact="detection" post="of respiratory viruses in hematopoietic cell transplant recipientsTranspl Infect"/>
  <result pre="GroupRandomised trial of efficacy and safety of inhaled zanamivir in" exact="treatment" post="of influenza A and B virus infectionsLancet19983529144187718819863784 124.NicholsonKGet al.Efficacy"/>
  <result pre="B virus infectionsLancet19983529144187718819863784 124.NicholsonKGet al.Efficacy and safety of oseltamivir in" exact="treatment" post="of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor"/>
  <result pre="Study GroupJAMA200028381016102410697061 126.MontoASWebsterAKeeneORandomized, placebo-controlled studies of inhaled zanamivir in the" exact="treatment" post="of influenza A and B: pooled efficacy analysisJ Antimicrob"/>
  <result pre="of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract" exact="infection" post="in hematopoietic cell transplant recipientsClin Infect Dis200744224524917173225 134.GhoshSet al.Respiratory"/>
  <result pre="immunoglobulinsBone Marrow Transplant200128327127511535995 135.LewinsohnDMet al.Phase I study of intravenous ribavirin" exact="treatment" post="of respiratory syncytial virus pneumonia after marrow transplantationAntimicrob Agents"/>
  <result pre="marrow transplantationAntimicrob Agents Chemother19964011255525578913463 136.DeVincenzoJPet al.Respiratory syncytial virus immune globulin" exact="treatment" post="of lower respiratory tract infection in pediatric patients undergoing"/>
  <result pre="al.Respiratory syncytial virus immune globulin treatment of lower respiratory tract" exact="infection" post="in pediatric patients undergoing bone marrow transplantation - a"/>
  <result pre="transplantation: failure of intravenous ribavirin therapyBone Marrow Transplant199923111209121110382964 144.GavinPJKatzBZIntravenous ribavirin" exact="treatment" post="for severe adenovirus disease in immunocompromised childrenPediatrics20021101 Pt 1e912093990"/>
  <result pre="1e912093990 145.LilesWCet al.Severe adenoviral nephritis following bone marrow transplantation: successful" exact="treatment" post="with intravenous ribavirinBone Marrow Transplant19931244094128275042 146.MannDet al.Failure of intravenous"/>
  <result pre="ribavirinBone Marrow Transplant19931244094128275042 146.MannDet al.Failure of intravenous ribavirin in the" exact="treatment" post="of invasive adenovirus infection following allogeneic bone marrow transplantation:"/>
  <result pre="al.Failure of intravenous ribavirin in the treatment of invasive adenovirus" exact="infection" post="following allogeneic bone marrow transplantation: a case reportJ Infect19983622272289570662"/>
  <result pre="pediatric hematopoietic stem cell transplantationBiol Blood Marrow Transplant20017738839411529489 149.LegrandFet al.Early" exact="diagnosis" post="of adenovirus infection and treatment with cidofovir after bone"/>
  <result pre="cell transplantationBiol Blood Marrow Transplant20017738839411529489 149.LegrandFet al.Early diagnosis of adenovirus" exact="infection" post="and treatment with cidofovir after bone marrow transplantation in"/>
  <result pre="Blood Marrow Transplant20017738839411529489 149.LegrandFet al.Early diagnosis of adenovirus infection and" exact="treatment" post="with cidofovir after bone marrow transplantation in childrenBone Marrow"/>
  <result pre="cidofovirBiol Blood Marrow Transplant2007131748117222755 152.SivaprakasamPet al.Improved outcome from invasive adenovirus" exact="infection" post="in pediatric patients after hemopoietic stem cell transplantation using"/>
  <result pre="and early interventionJ Pediatr Hematol Oncol2007292818517279003 153.YusufUet al.Cidofovir for the" exact="treatment" post="of adenoviral infection in pediatric hematopoietic stem cell transplant"/>
  <result pre="Pediatr Hematol Oncol2007292818517279003 153.YusufUet al.Cidofovir for the treatment of adenoviral" exact="infection" post="in pediatric hematopoietic stem cell transplant patientsTransplantation200681101398140416732176 154.NaesensLet al.Antiadenovirus"/>
  <result pre="156.FeuchtingerTet al.Safe adoptive transfer of virus-specific T-cell immunity for the" exact="treatment" post="of systemic adenovirus infection after allogeneic stem cell transplantationBr"/>
  <result pre="of virus-specific T-cell immunity for the treatment of systemic adenovirus" exact="infection" post="after allogeneic stem cell transplantationBr J Haematol20061341647616803570 157.TeramuraTet al.Quantitative"/>
  <result pre="infection after allogeneic stem cell transplantationBr J Haematol20061341647616803570 157.TeramuraTet al.Quantitative" exact="detection" post="of serum adenovirus in a transplant recipientLancet20023599321194512057576 158.CortezKJet al.Outbreak"/>
  <result pre="al.Molecular epidemiological investigation of a nosocomial outbreak of human metapneumovirus" exact="infection" post="in a pediatric hemato-oncology patient populationJ Clin Microbiol20094741221122419213698 160.NicholsWGet"/>
  <result pre="Clin Microbiol20094741221122419213698 160.NicholsWGet al.Prolonged outbreak of human parainfluenza virus 3" exact="infection" post="in a stem cell transplant outpatient department: insights from"/>
 </snippets>
</snippetsTree>
